RAPT Therapeutics (RAPT) EPS (Basic) (2020 - 2023)
Historic EPS (Basic) for Therapeutics (RAPT) over the last 4 years, with Q4 2023 value amounting to -$0.87.
- Therapeutics' EPS (Basic) fell 3329.56% to -$0.87 in Q4 2023 from the same period last year, while for Sep 2024 it was -$0.85, marking a year-over-year increase of 7230.94%. This contributed to the annual value of -$3.31 for FY2023, which is 2845.9% down from last year.
- Therapeutics' EPS (Basic) amounted to -$0.87 in Q4 2023, which was down 3329.56% from -$0.88 recorded in Q3 2023.
- Therapeutics' EPS (Basic)'s 5-year high stood at -$0.51 during Q2 2020, with a 5-year trough of -$0.88 in Q3 2023.
- Over the past 4 years, Therapeutics' median EPS (Basic) value was -$0.63 (recorded in 2021), while the average stood at -$0.66.
- Per our database at Business Quant, Therapeutics' EPS (Basic) skyrocketed by 158.73% in 2022 and then plummeted by 4036.09% in 2023.
- Quarter analysis of 4 years shows Therapeutics' EPS (Basic) stood at -$0.52 in 2020, then fell by 17.31% to -$0.61 in 2021, then decreased by 6.56% to -$0.65 in 2022, then plummeted by 33.3% to -$0.87 in 2023.
- Its EPS (Basic) stands at -$0.87 for Q4 2023, versus -$0.88 for Q3 2023 and -$0.74 for Q2 2023.